Want to join the conversation?
Pharmaceutical company $MYL said it has launched in US its Finasteride Tablets USP, 1 mg, a generic version of $MRK's Propecia. $MYL received final approval from the US FDA for ANDA for this product, which is indicated for the treatment of male pattern hair loss.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.